Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | -9.14%12.83K | -26.43%14.12K | 19.19K | |
| Other cash income from operating activities | -9.14%12.83K | -26.43%14.12K | --19.19K | ---- |
| Cash paid | 18.74%-750.4K | -11.53%-923.49K | -437.22%-828.03K | -154.13K |
| Payments to suppliers for goods and services | 22.10%-659.56K | -13.95%-846.63K | -382.04%-742.99K | ---154.13K |
| Other cash payments from operating activities | -18.20%-90.85K | 9.62%-76.86K | ---85.04K | ---- |
| Direct interest received | -61.55%18.07K | 915.17%46.98K | 14,829.03%4.63K | --31 |
| Operating cash flow | 16.57%-719.51K | -7.23%-862.39K | -421.87%-804.22K | ---154.1K |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | 24.30%-1.33M | 34.75%-1.76M | -193.94%-2.7M | -918.95K |
| Capital expenditure reported | 21.24%-1.31M | 34.69%-1.67M | -338.55%-2.55M | ---582.59K |
| Net PPE purchase and sale | ---- | ---- | ---46.27K | ---- |
| Net investment purchase and sale | 78.73%-20K | 5.99%-94.01K | ---100K | ---- |
| Net other investing changes | ---- | ---- | ---- | ---336.36K |
| Cash from discontinued investing activities | ||||
| Investing cash flow | 24.30%-1.33M | 34.75%-1.76M | -193.94%-2.7M | ---918.95K |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | -32.05%1.89M | 2.78M | 5.04M | |
| Net common stock issuance | -32.05%1.89M | --2.78M | ---- | --5.04M |
| Cash from discontinued financing activities | ||||
| Financing cash flow | -32.05%1.89M | --2.78M | ---- | --5.04M |
| Net cash flow | ||||
| Beginning cash position | 17.11%1.04M | -79.72%891.77K | 929.31%4.4M | --427.19K |
| Current changes in cash | -209.05%-166.43K | 104.35%152.63K | -188.30%-3.51M | --3.97M |
| End cash Position | -15.94%877.96K | 17.11%1.04M | -79.72%891.77K | --4.4M |
| Free cash from | 19.65%-2.03M | 25.68%-2.53M | -362.26%-3.41M | ---736.69K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |